Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published Dec 06, 24
1 min read


iDose® TR is a game-changing innovation in the treatment of glaucoma, providing a consistent and reliable option for managing intraocular pressure (IOP). In contrast to traditional eye drops that require daily administration, iDose® TR is a compact, implantable device designed to deliver a controlled release of medication directly into the eye over an longer period. This cutting-edge approach removes the hassle of daily applications, dramatically boosting patient adherence and overall treatment outcomes.

At Eye Center South, we are proud to offer iDose® TR as part of our all-encompassing glaucoma care. The device is placed during a minimally invasive procedure, designed with your ease in mind. Once in place, it delivers a steady dose of the prescribed medication, helping to maintain stable IOP levels and safeguarding your eyesight. Patients who struggle with the demands of frequent eye drop use can experience significant advantages from this next-generation treatment.



Visit for more info At Eye Center South